News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|February 15, 2011

Sexually Transmitted Diseases Treatment Guidelines, 2010

Author(s)OBGYN.net Staff

Prenatal screening and treatment of pregnant women can prevent chlamydial infection among neonates.

Prenatal screening and treatment of pregnant women can prevent chlamydial infection among neonates.

Sexually Transmitted Diseases Treatment Guidelines, 2010

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition

Updated: CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition

ByJoshua Fitch, Senior Editor

Published: July 24th 2026 | Updated: July 24th 2026

Statewide bundle reduces risk for deliveries complicated by postpartum hemorrhage | image credit: stock.adobe.com

Statewide bundle reduces risk for deliveries complicated by postpartum hemorrhage

ByJoshua Fitch, Senior Editor

July 21st 2026

CMS' obstetric G-codes cause confusion, perimenopause uncertainty, Zuranolone real-world data

ByJoshua Fitch, Senior Editor

July 17th 2026

CDC: 15% of US women report drinking alcohol during pregnancy

ByJoshua Fitch, Senior Editor

July 16th 2026

Importance of preoperative planning for cesarean delivery, with Beth Ann Clayton DNP, CRNA

ByBeth Ann Clayton, DNP, CRNA, FAANA, FAAN

July 14th 2026

Latest CME

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

HIV screening, PrEP counseling get stronger ACOG recommendation

Telehealth expands maternal-fetal medicine access, with Jeffrey Chapa, MD

Updated: CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition

Biomarker testing for preeclampsia with Lisa A. Bukovac, DO, FACOG

FDA grants 510(k) clearance to Roche's cobas BV/CV assay